… ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting LEIDEN, Netherlands … present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first …
… Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 15, … in Japan against a patent directed to its ADAR-mediated RNA editing platform Axiomer™. The opposition was filed in …
… Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases … ADAR RNA editing field in vivo proof of target engagement (RNA editing) leading to meaningful changes in biomarkers in …
… in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration LEIDEN, Netherlands & CAMBRIDGE, … RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced an expansion …
… ProQR Announces Upcoming Presentation at RNA Editing Summit LEIDEN, Netherlands & CAMBRIDGE, Mass., … RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that it will …
… ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly … to up to five targets u sing ProQR’s proprietary Axiomer ® RNA editing platform ProQR to receive $ 5 0 million …
… ProQR Announces Conference Call to Discuss the Axiomer® RNA Editing Platform LEIDEN, Netherlands & CAMBRIDGE, Mass., … call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently …
… and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration Partnership focused on utilizing … RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced a …
… ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB LEIDEN, the … ProQR will deliver a presentation on the Axiomer ® RNA editing technology during the TIDES: Oligonucleotide and …